P. Volling

Intensified hyperfractionated accelerated radiotherapy limits the additional benefit of simultaneous chemotherapy—results of a multicentric randomized German trial in advanced head-and-neck cancer

S. Staar, Volker Rudat, Hartmut Stuetzer et al. · International Journal of Radiation Oncology*Biology*Physics · 2001 · 359 citations

Radiation Medicine, Advanced Head-and-neck Cancer, Radiation Therapy +9

Surgical Treatment for Hypopharynx Carcinoma: Feasibility, Mortality, and Results

Hans Edmund Eckel, S. Staar, P. Volling et al. · Otolaryngology · 2001 · 117 citations

Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity

Christian Sittel, Serguei Drago Domínguez Ruiz, P. Volling et al. · Oral Oncology · 1999 · 104 citations

Medicine, Oral Cavity, Pathology +10

Efficacy of intensified hyperfractionated and accelerated radiotherapy and concurrent chemotherapy with carboplatin and 5-fluorouracil: Updated results of a randomized multicentric trial in advanced head-and-neck cancer

R. Semrau, Rolf‐Peter Mueller, Hartmut Stuetzer et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 92 citations

Advanced Head-and-neck Cancer, Radiation Therapy, Medicine +8

Carboplatin: The Better Platinum in Head and Neck Cancer?

P. Volling, M. Schröder, W. Rauschning et al. · Archives of Otolaryngology - Head and Neck Surgery · 1989 · 26 citations